Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004-2005 through 2007-2008.
about
Epidemiology of influenza virus types and subtypes in South Africa, 2009-2012.Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012.Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections.Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B VirusesImpact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia.Public health impact and economic benefits of quadrivalent influenza vaccine in Latin AmericaSchool absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015.The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model.Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in GermanyStriking Similarities in the Presentation and Duration of Illness of Influenza A and B in the Community: A Study Based on Sentinel Surveillance Networks in France and Turkey, 2010-2012.Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.Predictors of influenza among older adults in the emergency department.Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United StatesThe impact of influenza virus B in Italy: myth or reality?A comprehensive review of the epidemiology and disease burden of Influenza B in 9 European countries.Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model.Epidemiology of influenza B in Australia: 2001-2014 influenza seasons.Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy.Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approachThe rationale for quadrivalent influenza vaccines.Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.Influenza virus infections among patients attending emergency department according to main reason to presenting to ED: A 3-year prospective observational study during seasonal epidemic periods.Trends of influenza B during the 2010-2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy.A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza B Virus Monoclonal Antibody, MHAB5553A, in Healthy Volunteers.Comparison of laboratory-confirmed influenza and noninfluenza acute respiratory illness in healthcare personnel during the 2010-2011 influenza season.Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection.Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015.Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults.Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections.Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014.The burden of influenza B: a structured literature review
P2860
Q30363955-CF444ED2-A122-4A6C-80B4-3104F46D75F6Q30365872-76895676-73BD-49D5-9006-57FD3E222C0CQ30378619-A67FB716-EAE8-4068-A539-74E01EAB0349Q30383049-C2689CDB-B461-4AC7-8B25-0045E6AE6517Q30390901-3CDF95A1-6964-4EA9-86FB-3A0CED29EE6DQ33601906-BC5ED7E1-64BE-40C8-BCDB-4F27370177C8Q33619841-5ED87807-5D99-49AD-A876-2D371E6520A4Q33721397-1467FC2A-56A4-4246-90A1-6F16AF15CC4CQ35091073-5FD02639-8D74-4541-AEA2-6791AFA3205EQ35200964-19909415-488A-4B1C-B826-D16A34FD88BDQ35794869-0C0EB651-301D-4290-9E22-70395C6DFD84Q35821862-5486A174-2666-4B28-8EE7-50A15D33F3D3Q36177516-D495462F-D9FD-4EAF-9AE2-5529636BA3DAQ36977877-73D771B4-8E1F-4EE2-816E-3419DD53D3F6Q37011565-2D4F12A2-40A1-4280-B953-50443075F159Q37130821-0F4145E2-341F-4796-A8F2-27BA3E9B773BQ37416216-9FD9AD29-5189-4E95-ACA6-FE8F07FF6ACAQ37638402-A60B587F-6247-4BCC-9299-FADEA91E3CFAQ37669436-19A5C5EB-115D-4246-B2F0-B3B33370019FQ37713755-6C95C5A3-0B06-499F-A19E-CE9912B26E9BQ37976542-FB8741FF-27A6-4E11-A0B3-5F6EB0694F51Q38059737-864A866A-8D50-4568-AC99-501F50FCC603Q38660898-014354C5-2654-460E-AFB9-AFE78C75017AQ39322780-384E877F-448D-499D-B806-B20CBDBC11C3Q40081362-71B68C6C-178D-46ED-A779-1945780F43CEQ40122593-0E3E42D1-18E5-467A-8599-E150913C4DDDQ40180049-F80C9DC2-AC23-42F0-9452-B9D50F44EA37Q40211305-18D42D38-D616-455C-B483-1C3E798FD48CQ42218621-7DC44969-6B4C-40A8-BF6A-7FE3287D07CFQ47149689-479E8CA7-46CB-4F90-A4F2-001BC2EE3A43Q50420352-1C5432AB-1DD8-403C-8036-AE4199C4E79EQ52657377-B59597DF-1031-4BBE-80A4-FBCCE2DCC80BQ55220726-B42265A6-E5F6-43A1-95B0-726C073BD3D7Q57943670-0AF855DB-AD7C-4E94-97D3-8A37ACC27330
P2860
Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004-2005 through 2007-2008.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of clinical feature ...... : 2004-2005 through 2007-2008.
@en
Comparison of clinical feature ...... : 2004-2005 through 2007-2008.
@nl
type
label
Comparison of clinical feature ...... : 2004-2005 through 2007-2008.
@en
Comparison of clinical feature ...... : 2004-2005 through 2007-2008.
@nl
prefLabel
Comparison of clinical feature ...... : 2004-2005 through 2007-2008.
@en
Comparison of clinical feature ...... : 2004-2005 through 2007-2008.
@nl
P2093
P2860
P50
P1476
Comparison of clinical feature ...... : 2004-2005 through 2007-2008.
@en
P2093
Burney A Kieke
James G Donahue
Mary F Vandermause
P2860
P356
10.1111/J.1750-2659.2011.00263.X
P577
2011-05-25T00:00:00Z